Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000311953 | SCV000345761 | pathogenic | not provided | 2016-08-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000984172 | SCV002189903 | pathogenic | Tyrosinemia type I | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr321*) in the FAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FAH-related conditions. ClinVar contains an entry for this variant (Variation ID: 291075). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000984172 | SCV004195901 | likely pathogenic | Tyrosinemia type I | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000984172 | SCV001132186 | likely pathogenic | Tyrosinemia type I | 2014-11-17 | no assertion criteria provided | clinical testing |